Skip to main content
. 2016 Dec 5;27(2):139–142. doi: 10.1016/j.bmcl.2016.12.010

Table 2.

Cytotoxicity in diverse mammalian cell lines.

Compound Cytotoxicity
MCC (μM)a
CC50 (μM)b
Vero HeLa MDCK HEL CRFK MT-4
4a >100 >100 >100 >100 >100 >125
4b >100 >100 >100 >100 >100 96
4c >100 >100 >100 >100 >100 76
4d >100 >100 >100 >100 >100 64
4e >100 >100 >100 >100 >100 >125
4f >100 >100 >100 >100 >100 >125
4g 100 >100 >100 >100 >100 >125
4h 100 ⩾100 >100 >100 >100 >125
4i >100 >100 >100 >100 >100 >125
4j >100 >100 >100 >100 >100 >125
4k >100 >100 >100 >100 >100 >125
4l >100 >100 >100 >100 >100 >125
4m ⩾100 >100 >100 100 >100 50
5 >100 >100 >100 >100 >100 >125

The following cell lines were used: Vero, African green monkey kidney cells; HeLa, cervix carcinoma cells; MDCK, Madin-Darby canine kidney cells; HEL, human embryonic lung fibroblast cells; CRFK, Crandell-Rees feline kidney cells; MT-4, human T-lymphoblast cells.

a

MCC: minimal cytotoxic concentration, or compound concentration producing minimal alterations in cell morphology, as detected by microscopical inspection.

b

CC50: 50% cytotoxic concentration, determined by the colorimetric and formazan-based MTS cell viability test.